NEW ZEALAND DATA SHEET - Medsafe
NEW ZEALAND DATA SHEET Page 2 of 20 Fentanyl Sandoz is also indicated in the management of opioid-responsive chronic severe pain of non¬malignant origin in opioid tolerant patients, after other conservative methods of
Tags:
Sheet, Data, Zealand, New zealand data sheet, Fentanyl
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
GUIDELINE FOR ADMINISTRATION OF FENTANYL FOR PAIN …
rcp.nshealth.caRCP PROVINCIAL GUIDELINE FOR ADMINIS TRATION OF FENTANYL1 IN LABOUR GUIDELINE FOR ADMINISTRATION OF FENTANYL FOR PAIN RELIEF IN LABOUR INT RODUCT ION Intr avenous (IV) Fentanyl is a good option for pain management during labour and should
Bupivacaine Hydrochloride 1mg/ml and Fentanyl …
www.mhra.gov.ukMHRA PAR; BUPIVACAINE HYDROCHLORIDE 1MG/ML AND FENTANYL 2MICROGRAM/ML SOLUTION FOR INJECTION/INFUSION, PL 12064/0062 4 INTRODUCTION Based on the review of the data on quality, safety and efficacy, the UK granted a marketing
Hydrochloride, Fentanyl, Bupivacaine hydrochloride 1mg ml and fentanyl, Bupivacaine
Transmucosal Immediate Release Fentanyl (TIRF) Products ...
www.tirfremsaccess.comTransmucosal Immediate Release Fentanyl (TIRF) Products Risk Evaluation and Mitigation Strategy (REMS) Education Program for Prescribers and Pharmacists
Fentanyl Safety Information for First Responders
www.vdh.virginia.govFentanyl Safety Information for First Responders . Background . An additional risk in the ongoing opioid epidemic is the potential exposure of first responders to fentanyl and
Fentanyl and its analogues - 50 years on
www.unodc.org4 Nonmedical use of fentanyl and its analogues can have severe health consequences. Tolerance and depen-dence develop very fast, and may reach extreme levels.
Analogue, Fentanyl, Fentanyl and its analogues 50, Fentanyl and its analogues
FENTANYL Latest Revision: August 18, 2005
www.swgdrug.orgCOMPOUND RRT COMPOUND RRT acetyl thebol 0.84 allobarbital 0.26 acetylated dipyrone 0.68 hexadecane 0.26 acetylprocaine 0.70 ibuprofen 0.26
August, Revisions, Latest, Fentanyl, August 18, Fentanyl latest revision
Background - Auckland City Hospital
www.adhb.govt.nzStarship Children’s Health Clinical Guideline Note: The electronic version of this guideline is the version currently in use. Any printed version can
2012 2013 2014 2015 2016 2017 - Connecticut
www.ct.govConnecticut Accidental Drug Intoxication Deaths Office of the Chief Medical Examiner *Some deaths had combinations of drugs; pure ethanol intoxications are not included.